4.56
                                            Precedente Chiudi:
              $4.75
            Aprire:
              $4.71
            Volume 24 ore:
                841.06K
            Relative Volume:
              1.38
            Capitalizzazione di mercato:
                $441.77M
            Reddito:
              -
            Utile/perdita netta:
              $-238.77M
            Rapporto P/E:
              -0.1701
            EPS:
                -26.808
            Flusso di cassa netto:
                $-216.62M
            1 W Prestazione:
              -5.20%
            1M Prestazione:
              +13.43%
            6M Prestazione:
                -0.65%
            1 anno Prestazione:
              -59.68%
            Alumis Inc Stock (ALMS) Company Profile
Nome
                  
                      Alumis Inc
                    
                Settore
                  Industria
                  Telefono
                  
                      650-231-6625
                    
                Indirizzo
                  
                      280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
                    
                Confronta ALMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ALMS
                            
                             
                        Alumis Inc 
                           | 
                    4.56 | 494.31M | 0 | -238.77M | -216.62M | -26.81 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2025-07-25 | Iniziato | Wells Fargo | Overweight | 
| 2025-06-10 | Ripresa | Guggenheim | Buy | 
| 2025-01-30 | Iniziato | Oppenheimer | Outperform | 
| 2024-10-31 | Iniziato | Robert W. Baird | Outperform | 
| 2024-10-17 | Iniziato | H.C. Wainwright | Buy | 
| 2024-07-23 | Iniziato | Cantor Fitzgerald | Overweight | 
| 2024-07-23 | Iniziato | Guggenheim | Buy | 
| 2024-07-23 | Iniziato | Leerink Partners | Outperform | 
| 2024-07-23 | Iniziato | Morgan Stanley | Overweight | 
                    Mostra tutto
                    
                  
                Alumis Inc Borsa (ALMS) Ultime notizie
Is a relief rally coming for Alumis Inc. holdersWeekly Loss Report & Verified Stock Trade Ideas - newser.com
Real time scanner hits for Alumis Inc. explainedJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Will Alumis Inc. continue its uptrendQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Will Alumis Inc. stock remain a Wall Street favoriteFed Meeting & Daily Growth Stock Tips - newser.com
Will Alumis Inc. stock benefit from upcoming earnings reportsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
How to manage a losing position in Alumis Inc.Weekly Stock Report & Consistent Profit Trade Alerts - newser.com
Why Alumis Inc. stock is recommended by analystsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com
Will Alumis Inc. stock benefit from sector rotationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Momentum divergence signals in Alumis Inc. chart2025 Short Interest & Daily Profit Focused Screening - newser.com
Is Alumis Inc. a candidate for recovery playQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Chart based exit strategy for Alumis Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Analyzing drawdowns of Alumis Inc. with statistical toolsJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
Is Alumis Inc. stock positioned for long term growthJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Pattern recognition hints at Alumis Inc. upsideJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Will Alumis Inc. outperform the marketMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com
Tools to assess Alumis Inc.’s risk profileJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment - MSN
Sentiment Watch: Will Alumis Inc. stock outperform value stocksJuly 2025 Opening Moves & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará
Alumis Inc Azioni (ALMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):